|Bid||65.55 x 100|
|Ask||106.63 x 100|
|Day's Range||77.64 - 79.13|
|52 Week Range||56.59 - 115.00|
|PE Ratio (TTM)||59.97|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||91.17|
The Loveland, Colorado-based company said it had a loss of 14 cents per share. Earnings, adjusted for pretax expenses, were 63 cents per share. The maker of veterinary products posted revenue of $36 million ...
NEW YORK, NY / ACCESSWIRE / February 28, 2018 / Heska Corporation (NASDAQ: HSKA ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 28, 2018 at 11:00 AM Eastern ...
Sets Analyst Day for May 15, 2018 in New York City to Discuss New Products and Initiatives LOVELAND, Colo. , Feb. 28, 2018 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the ...
LOVELAND, Colo. , Feb. 9, 2018 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, ...
NEW YORK, Jan. 30, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Immune ...
"Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced today that Catherine Grassman is promoted to Vice President, Chief Accounting Officer and Controller following the departure of John McMahon, Vice President and Chief Financial Officer. "Catherine is a deeply experienced financial executive who already knows Heska well and is highly qualified to serve as vice president and principal accounting officer," commented Kevin Wilson, President and Chief Executive Officer. "Catherine has been a central figure in the Company's accounting and finance leadership throughout 2017.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Heska Corp. Here are 5 ETFs with the largest exposure to HSKA-US. Comparing the performance and risk of Heska Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
The Loveland, Colorado-based company said it had profit of 40 cents per share. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
- 16% growth in year over year core blood diagnostics instruments and consumables revenue - Gross margins up 210bps year over year to 43.1% - Records $3.8 million of operating income in the quarter, bringing ...
"Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced today an agreement to supply over 100 PetVetCare Centers ("PetVetCare") veterinary hospitals with in-house laboratory diagnostic equipment and supplies through 2024, which may be extended by the Parties. Under the agreement, Heska's in-house blood diagnostics analyzers will be placed into PetVetCare's general, specialty referral, and emergency hospitals throughout the United States. PetVetCare is one of the nation's top five veterinary healthcare providers and currently represents roughly 0.5% of full-service veterinary hospitals in the United States.
"Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced today the release of the new Element COAG™ Veterinary Analyzer. The compact bench top analyzer delivers coagulation and blood typing parameters to complement Heska's Element leading chemistry, hematology, immunodiagnostics blood gas and electrolyte analyzers. Within minutes and with only 100uL of sample, Element COAG delivers accurate PT/aPTT (coagulation), Canine Fibrinogen, Equine Fibrinogen, Canine DEA 1.1 Blood Typing and Feline A/B Blood Typing.
LOVELAND, Colo. , Oct. 12, 2017 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, ...
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Heska Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)
Categories: Yahoo FinanceGet free summary analysis Heska Corp. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 34.34 million, Net Earnings of USD 3.33 million. Gross margins widened from 42.32% to 43.48% compared to the same period last year, operating (EBITDA) margins now 16.48% from 15.59%. Change in operating cash ... Read more (Read more...)
TESARO's (TSRO) marketing application for approval of its PARP-inhbitor Zejula as monotherapy for the maintenance treatment of ovarian cancer gets positive CHMP opinion.
The Zacks Analyst Blog Highlights: KEMET, Heska, Spirit AeroSystems, American Woodmark and Kraton
Biotech sector is performing well in 2017 due to an increase in FDA approvals, new product sales ramp up, R&D success and innovation, strong clinical study results and continued strong performance of legacy products.
The S&P 500 surged 268% since bottoming in March 2009, while the index registered a staggering $2.04 trillion in market value since Trump's election last November
Zacks.com featured highlights Sanderson Farm, Heska Corp, Vanda Pharmaceuticals Lantheus and NVR